AstraZeneca

News

AZ trumpets Farxiga survival data in renal disease at ESC 20...

AstraZeneca’s Farxiga is already ahead of rivals in the SGLT2 inhibitor field in heart failure, and now looks set to repeat that success in renal disease after reporting stella

News

AZ expands phase 3 trials of COVID-19 vaccine frontrunner in...

AstraZeneca has expanded development of COVID-19 vaccine AZD1222 into the US, beginning a phase 3 clinical trial across all adult age groups.

News

Chasing Regeneron, AZ starts trials of its COVID-19 antibody...

The first patients have been dosed in a trial of two AstraZeneca antibodies, collectively known as AZD7442, that are being developed to both treat and prevent coronavirus infec

News

AZ aims to cut cancer clinic visits with new Imfinzi regimen

The FDA is to review data supporting AstraZeneca’s Imfinzi (durvalumab) cancer immunotherapy in a new four-week regimen that will halve the number of required clinic visits for patients wit

News

The unprecedented challenge of pricing a coronavirus vaccine

EU places firm order for AZ/Oxford Uni’s ChAdOx1 COVID-19 va...

The European Commission has placed its first advance order for a coronavirus vaccine, snapping up 300 million doses of AstraZeneca’s ChAdOx1 candidate developed by the Universi

News